
New York, US-based biotechnology company Novavax on Friday announced that its Covid-19 vaccine was 89.3% effective in preventing Covid-19 in a trial conducted Read More
reported by Business Insider India at Business Insider India
New York, US-based biotechnology company Novavax on Friday announced that its Covid-19 vaccine was 89.3% effective in preventing Covid-19 in a trial conducted Read More
reported by Business Insider India at Business Insider India
Recent Comments